Data / Form D filings / Azora Therapeutics, Inc.
Azora Therapeutics, Inc.: Form D filings
Azora Therapeutics, Inc., a pharmaceuticals company in Encino, CA, filed 2 Form D notices with the SEC between 2021 and 2023. The latest, on August 9, 2023, reports $581,449 sold of a $596,426 offering to 11 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4267 Valley Meadow Road, Encino, CA, 91436
- Phone
- (818) 276-6726
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1866534
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 9, 2023 | New notice | $596,426 | $581,449 | $14,977 | 11 | Aug 2, 2023 | sec.gov |
| Jun 14, 2021 | New notice | $8,359,902 | $7,734,902 | $625,000 | 108 | Jun 1, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Dennis Brown | Director | |
| Julie Saiki | Executive Officer, Director | |
| Matthew Davidson | Executive Officer, Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Aug 7, 2023 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Azora Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.